These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 20108221)

  • 21. Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11-13 weeks.
    Poon LC; Staboulidou I; Maiz N; Plasencia W; Nicolaides KH
    Ultrasound Obstet Gynecol; 2009 Aug; 34(2):142-8. PubMed ID: 19644947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal serum insulin-like growth factor-binding protein-3 (IGFBP-3) at 11-13 weeks in preeclampsia.
    Sifakis S; Akolekar R; Kappou D; Mantas N; Nicolaides KH
    J Hum Hypertens; 2012 Apr; 26(4):253-8. PubMed ID: 21368777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal venous Doppler characteristics are abnormal in pre-eclampsia but not in gestational hypertension.
    Gyselaers W; Staelens A; Mesens T; Tomsin K; Oben J; Vonck S; Verresen L; Molenberghs G
    Ultrasound Obstet Gynecol; 2015 Apr; 45(4):421-6. PubMed ID: 24890401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation.
    Spencer K; Yu CK; Savvidou M; Papageorghiou AT; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Jun; 27(6):658-63. PubMed ID: 16493628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum PlGF compared with PAPP-A in first trimester screening for preterm pre-eclampsia: Adjusting for the effect of aspirin treatment.
    Wright D; Tan MY; O'Gorman N; Syngelaki A; Nicolaides KH
    BJOG; 2022 Jul; 129(8):1308-1317. PubMed ID: 35015330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE.
    Tan MY; Wright D; Syngelaki A; Akolekar R; Cicero S; Janga D; Singh M; Greco E; Wright A; Maclagan K; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):743-750. PubMed ID: 29536574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficiency of first-trimester uterine artery Doppler, a-disintegrin and metalloprotease 12, pregnancy-associated plasma protein a, and maternal characteristics in the prediction of preeclampsia.
    Goetzinger KR; Zhong Y; Cahill AG; Odibo L; Macones GA; Odibo AO
    J Ultrasound Med; 2013 Sep; 32(9):1593-600. PubMed ID: 23980220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia.
    Akolekar R; Zaragoza E; Poon LC; Pepes S; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Nov; 32(6):732-9. PubMed ID: 18956425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early pregnancy screening for hypertensive disorders in women without a-priori high risk.
    Abdelaziz A; Maher MA; Sayyed TM; Bazeed MF; Mohamed NS
    Ultrasound Obstet Gynecol; 2012 Oct; 40(4):398-405. PubMed ID: 22689569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The utility of first trimester uterine artery Doppler, placental volume and PAPP-A levels alone and in combination to predict preeclampsia.
    Yücel B; Gedikbasi A; Dündar O; Olgac Y; Yıldırım D; Yıldırım G; Polat I
    Pregnancy Hypertens; 2016 Oct; 6(4):269-273. PubMed ID: 27939466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation.
    O'Gorman N; Wright D; Syngelaki A; Akolekar R; Wright A; Poon LC; Nicolaides KH
    Am J Obstet Gynecol; 2016 Jan; 214(1):103.e1-103.e12. PubMed ID: 26297382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Could first-trimester assessment of placental functions predict preeclampsia and intrauterine growth restriction? A prospective cohort study.
    Abdel Moety GA; Almohamady M; Sherif NA; Raslana AN; Mohamed TF; El Moneam HM; Mohy AM; Youssef MA
    J Matern Fetal Neonatal Med; 2016; 29(3):413-7. PubMed ID: 25594239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation.
    Tsiakkas A; Saiid Y; Wright A; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2016 Jul; 215(1):87.e1-87.e17. PubMed ID: 26875953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy.
    Park FJ; Leung CH; Poon LC; Williams PF; Rothwell SJ; Hyett JA
    Aust N Z J Obstet Gynaecol; 2013 Dec; 53(6):532-9. PubMed ID: 23919594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation.
    Gallo DM; Wright D; Casanova C; Campanero M; Nicolaides KH
    Am J Obstet Gynecol; 2016 May; 214(5):619.e1-619.e17. PubMed ID: 26627730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired placentation in women with chronic hypertension who develop pre-eclampsia.
    Panaitescu AM; Akolekar R; Kametas N; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Oct; 50(4):496-500. PubMed ID: 28470791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of uterine artery Doppler in interpreting low PAPP-A values in first-trimester screening for Down syndrome in pregnancies at high risk of impaired placentation.
    Herraiz I; López-Jiménez EA; García-Burguillo A; Nieto O; Villar OP; Escribano D; Galindo A
    Ultrasound Obstet Gynecol; 2009 May; 33(5):518-23. PubMed ID: 19402101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uterine artery Doppler at 30-33 weeks' gestation in the prediction of preeclampsia.
    Lai J; Poon LC; Pinas A; Bakalis S; Nicolaides KH
    Fetal Diagn Ther; 2013; 33(3):156-63. PubMed ID: 23445882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uterine artery Doppler and biochemical markers (PAPP-A, PIGF, sFlt-1, P-selectin, NGAL) at 11 + 0 to 13 + 6 weeks in the prediction of late (> 34 weeks) pre-eclampsia.
    Youssef A; Righetti F; Morano D; Rizzo N; Farina A
    Prenat Diagn; 2011 Dec; 31(12):1141-6. PubMed ID: 22034048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of pre-eclampsia and its subtypes in high-risk cohort: hyperglycosylated human chorionic gonadotropin in multivariate models.
    Murtoniemi K; Villa PM; Matomäki J; Keikkala E; Vuorela P; Hämäläinen E; Kajantie E; Pesonen AK; Räikkönen K; Taipale P; Stenman UH; Laivuori H
    BMC Pregnancy Childbirth; 2018 Jul; 18(1):279. PubMed ID: 29970026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.